Literature DB >> 10155300

Epidemiology, therapy and costs of nosocomial infection.

R Gálvez-Vargas1, A Bueno-Cavanillas, M García-Martín.   

Abstract

In the current climate of cost containment and quality control, nosocomial infection is a worrisome adverse event in hospital care. Hospitalised patients require care for increasingly severe illnesses, and are therefore more susceptible to infection, especially by opportunistic micro-organisms. It is thus necessary to accurately assess and adjust for the severity of the underlying illness in studies of risk factors involved in nosocomial infections. The appearance of new diagnostic and therapeutic techniques provides novel opportunities for infection control and represents a constant challenge to hospital systems. The continuous selection of resistant flora, together with the identification of new pathogens, calls for a reconsideration of hospital policies regarding the dispensation of antibiotics. Epidemiological surveillance continues to be the most important aspect of attempts to monitor infection control programmes, and to identify changes in risk factors that may increase the infection rate. Among the major challenges now facing the infection control practitioner is the use of nosocomial infection rates as an indicator of quality of care. Awareness of infection statistics would serve as a stimulus to the prevention and control of infection, but would be useless if not accompanied by adequate systems to guarantee the comparability of data from different studies and centres. Suitably sensitive and specific surveillance systems should be developed, and the use of site-specific and procedure-specific infection rates adjusted for the patient's intrinsic risk should be encouraged.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10155300     DOI: 10.2165/00019053-199507020-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  124 in total

Review 1.  Containing costs of antimicrobials in the hospital: a critical evaluation.

Authors:  N J Ehrenkranz
Journal:  Am J Infect Control       Date:  1989-10       Impact factor: 2.918

Review 2.  Antibiotics: the antipyretics of choice?

Authors:  M J DiNubile
Journal:  Am J Med       Date:  1990-12       Impact factor: 4.965

3.  Environmental factors in nosocomial infection-a selective focus.

Authors:  J E McGowan
Journal:  Rev Infect Dis       Date:  1981 Jul-Aug

4.  Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination.

Authors:  R W Haley; D H Culver; W M Morgan; J W White; T G Emori; T M Hooton
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

5.  The nationwide nosocomial infection rate. A new need for vital statistics.

Authors:  R W Haley; D H Culver; J W White; W M Morgan; T G Emori
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

Review 6.  Nosocomial infections in surgical patients: developing valid measures of intrinsic patient risk.

Authors:  R W Haley
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

7.  Automated postdischarge surveillance for postpartum and neonatal nosocomial infections.

Authors:  K F Holbrook; V F Nottebart; S R Hameed; R Platt
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

8.  Definition and comparability of nosocomial infection rates.

Authors:  R Madison; A A Afifi
Journal:  Am J Infect Control       Date:  1982-05       Impact factor: 2.918

9.  [Relationship between nosocomial infection and hospital mortality. Multicenter study].

Authors:  G Rodríguez-Rumayor; C Fernández Pérez; A Delgado García; M Carrasco Asenjo; E Andradas Aragonés; S de Juan García; M Zimmermann Verdejo
Journal:  Med Clin (Barc)       Date:  1993-01-09       Impact factor: 1.725

10.  Hospital acquired infections surveillance and control in intensive care services. Results of an incidence study.

Authors:  M Costantini; P M Donisi; M G Turrin; L Diana
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

View more
  3 in total

Review 1.  Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.

Authors:  M Young; G L Plosker
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Nosocomial infections in critically ill infectious disease patients: results of a 7-year focal surveillance.

Authors:  B Barsić; I Beus; E Marton; J Himbele; I Klinar
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

3.  Correlation between Overconfidence and Learning Motivation in Postgraduate Infection Prevention and Control Training.

Authors:  Milena Trifunovic-Koenig; Stefan Bushuven; Bianka Gerber; Baerbel Otto; Markus Dettenkofer; Florian Salm; Martin R Fischer
Journal:  Int J Environ Res Public Health       Date:  2022-05-09       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.